REBECCA CRISWELL: Open Payments
NPI 1316314768 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 18 payments from 7 companies in 2025. Trend: 2023 $315 · 2024 $322 · 2025 $1,045
Travel & lodging: $565Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $830 |
| ABBVIE INC. | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| PFIZER INC. | 2 | $39 |
| Gilead Sciences, Inc. | 1 | $27 |
| Celgene Corporation | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $24 |
Products named: 2ND GEN CENTRIMAG PRIMARY CONSOLE, KEYTRUDA, XTANDI, IMBRUVICA, Trodelvy, REBLOZYL, BRUKINSA, EPKINLY.
Industry payments across TN — which companies pay providers there.
